Argonaut further develops cGMP sites
Expansion features a new lyophilization center to meet point-of-care demand
Argonaut Manufacturing Services, a contract manufacturing organization (CMO) supporting the life sciences, molecular diagnostics and biopharma sectors, is expanding its cGMP (current good manufacturing practice) facilities in the greater San Diego area of Carlsbad, CA. This will bring Argonaut's manufacturing space to over 90,000 square feet.
The new facility space, which is expected to be fully operational by later this year, will be equipped with automation upgrades to complement Argonaut's existing formulation, fill-and-finish offerings. It will also house its new lyophilization center, which will aim to meet stability needs of point-of-care tests worldwide. This site will feature patented enabling technologies and processes that will lower the cost per device and improve quality and flexibility, the CMO says.
"I'm excited that our team and our state-of-the-art facilities are well positioned to respond to the needs of our customers and the increasing demand for our services," says Wayne Woodard, Argonaut founder and CEO. "Our expansion will change the landscape and capacity for regulated cGMP lyophilization service, so desperately needed, in the point-of-care market today and in the future. This expansion in capacity—combined with the technology advancements in lyophilization we have made—are dramatically advancing our timelines."
